Skip to main content
. 2022 Apr 21;607(7917):128–134. doi: 10.1038/s41586-022-04778-y

Extended Data Fig. 5. Anti-SARS-CoV-2 RBD monoclonal antibodies.

Extended Data Fig. 5

a, Graphs show half-maximal concentration (EC50) of n = 459 monoclonal antibodies measured by ELISA against Wuhan-Hu-1 RBD after prime6, 1.3- and 5-months post-Vax25,6, and 1 month after Vax3. b, Graph showing EC50 of n = 459 monoclonal antibodies as categorized as either persisting clones detected at multiple time points, unique clones where sequences were clonally expanded but detected at a single time point, or singlets where mAbs were derived from sequences detected once at a single time point. c-d, EC50 (c) or IC50 neutralizing activity (d) of n = 246 monoclonal antibodies derived from shared clones only. Lines connect the related clones at the indicated time point. Red bars and numbers in a, and b, indicate geometric mean values. Statistical significance was determined by two-tailed Kruskal Wallis test with subsequent Dunn’s multiple comparisons. All experiments were performed at least twice.